Skip to main content

Advertisement

SpringerLink
Log in

Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

For patients with chronic hepatitis due to hepatitis B virus (HBV), factors predicting hepatocellular carcinoma (HCC) other than high levels of HBV-DNA and alanine aminotransferase (ALT) are needed to prevent HCC development, as many patients with chronic HBV infection fulfill these conditions. The purpose of this study was to clarify factors predictive of HCC development for those patients.

Methods

The study was a systematic cohort analysis of 303 consecutive patients with hepatitis B e-antigen, receiving laparoscopic examination for assessment of liver disease. Laparoscopic, histological, and clinical characteristics were investigated as related to HCC development.

Results

HCC occurred in 27 patients during a mean follow-up of 8.0 ± 5.0 years, at the age of 37–72 years. Significant associations with HCC development were shown for liver cirrhosis, histological activity grade, reddish markings, and older age. Multivariate analysis revealed that HCC development was strongly associated with older age and male gender (P = 0.002 and P = 0.043, respectively). HCC occurred more frequently in patients of age ≥30 years even with early stage than in patients of age <30 years (P = 0.031). Severe reddish markings, a laparoscopic finding of widespread parenchymal destruction, were highly associated with HCC development in patients of age ≥30 years at diagnosis (odds ratio = 1.67, P = 0.034), while histological activity grade and ALT level were not (P = 0.075 and P = 0.69, respectively).

Conclusions

HCC development is associated with older age, male gender, and liver cirrhosis. Reddish markings, rather than histological activity or ALT level, can be useful to predict HCC for HBV patients of age ≥30 years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

HBV:

Hepatitis B virus

HCC:

Hepatocellular carcinoma

ALT:

Alanine aminotransferase

HCV:

Hepatitis C virus

AST:

Aspartate aminotransferase

References

  1. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981;2:1129–33.

    Article  CAS  PubMed  Google Scholar 

  2. Liaw YF, Tai DI, Chu CM, et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology. 1986;90:263–7.

    CAS  PubMed  Google Scholar 

  3. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335–52.

    Article  PubMed  Google Scholar 

  4. Tong MJ, Hsien C, Hsu L, et al. Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States. Hepatology. 2008;48:1070–8.

    Article  PubMed  Google Scholar 

  5. Lai CL, Lok AS, Lin HJ, et al. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children. Lancet. 1987;2:877–80.

    Article  CAS  PubMed  Google Scholar 

  6. Orito E, Ichida T, Sakugawa H, et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology. 2001;34:590–4.

    Article  CAS  PubMed  Google Scholar 

  7. Sumi H, Yokosuka O, Seki N, et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology. 2003;37:19–26.

    Article  CAS  PubMed  Google Scholar 

  8. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002;347:168–74.

    Article  CAS  PubMed  Google Scholar 

  9. Kalk H. Dienchronishen Verlaufsformen der Hepatitis epidemica in Beziehung zu ihren anatomischen Grudlagen. DMW. 1947;72:308–13.

    Article  CAS  Google Scholar 

  10. Kalk H, Wildhirt E. Lehrbuch und Atlas der Laparoskopie and Leberpunction. Stuttgart: Georg Thieme Verlag; 1962.

    Google Scholar 

  11. Poniachik J, Bernstein DE, Reddy KR, et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc. 1996;43:568–71.

    Article  CAS  PubMed  Google Scholar 

  12. Cardi M, Muttillo IA, Amadori L, et al. Superiority of laparoscopy compared to ultrasonography in diagnosis of widespread liver diseases. Dig Dis Sci. 1997;42:546–8.

    Article  CAS  PubMed  Google Scholar 

  13. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97:2614–8.

    Article  PubMed  Google Scholar 

  14. Arase Y, Suzuki F, Suzuki Y, et al. Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses. Hepatol Res. 2008;38:877–85.

    Article  PubMed  Google Scholar 

  15. Shiraki K, Shimizu A, Takase K, et al. Prospective study of laparoscopic findings with regard to the development of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Gastrointest Endosc. 2001;53:449–55.

    Article  CAS  PubMed  Google Scholar 

  16. Shibayama T, Mori S, Ohtake H, et al. Risk factors of hepatocellular carcinoma in chronic hepatitis C and cirrhosis: special reference to laparoscopic findings. Dig Endosc. 1999;11:24–31.

    Article  Google Scholar 

  17. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513–20.

    Article  CAS  PubMed  Google Scholar 

  18. Shimada N, Itoshima T, Ohta W, et al. A new classification of liver surface pictures by peritoneoscopic photography. Gastroenterol Endosc. 1971;13:68–76.

    Google Scholar 

  19. Watanabe M, Hirakawa H, Ikeda S, et al. Peritoneoscopy as an aid in intravenous injection of indocyanine green (ICG). Endoscopy. 1985;17:149–52.

    Article  CAS  PubMed  Google Scholar 

  20. Ito T, Itoshima T, Ukida M, et al. Peritoneoscopy of the liver stained by intravenous injection of indocyanine green-experimental and clinical studies. Gastroenterol Jpn. 1983;18:593–8.

    CAS  PubMed  Google Scholar 

  21. Michitaka K, Onji M, Horiike N, et al. Hepatitis B virus replication in dark reddish patchy markings appearing on the hepatic surface. Gastrointest Endosc. 1990;36:15–8.

    Article  CAS  PubMed  Google Scholar 

  22. Kudo M. Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis. 1999;19:297–309.

    Article  CAS  PubMed  Google Scholar 

  23. Peterson MS, Baron RL. Radiologic diagnosis of hepatocellular carcinoma. Clin Liver Dis. 2001;5:123–44.

    Article  CAS  PubMed  Google Scholar 

  24. Ohta W. Significance of reddish asteroidal and meshwork markings on the liver surface of chronic hepatitis observed by peritoneoscopy-observation of liver cell necrosis in relation to the portal and hepatic veins. Acta Hepatol Jpn. 1975;16:448–63.

    Google Scholar 

  25. Shibayama T, Ohtake H, Hishima T. Formation and clinical significance of reddish markings on the liver surface: activity of chronic liver disease. Dig Endosc. 2003;15:100–7.

    Article  Google Scholar 

  26. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349:825–32.

    Article  CAS  PubMed  Google Scholar 

  27. Al-Chalabi T, Boccato S, Portmann BC, et al. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol. 2006;45:575–83.

    Article  PubMed  Google Scholar 

  28. Kubota J, Ikeda F, Terada R, et al. Mortality rate of patients with asymptomatic primary biliary cirrhosis diagnosed at age 55 years or older is similar to that of the general population. J Gastroenterol. 2009;44:1000–6.

    Article  PubMed  Google Scholar 

  29. Piao CY, Fujioka S, Iwasaki Y, et al. Lamivudine treatment in patients with HBV-related hepatocellular carcinoma-using an untreated, matched control cohort. Acta Med Okayama. 2005;59:217–24.

    CAS  PubMed  Google Scholar 

  30. Kuzuya T, Katano Y, Kumada T, et al. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. J Gastroenterol Hepatol. 2007;22:1929–35.

    Article  CAS  PubMed  Google Scholar 

  31. Koda M, Matunaga Y, Kawakami M, et al. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology. 2007;23:297–306.

    Article  Google Scholar 

  32. Ngo Y, Benhamou Y, Thibault V, et al. An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load. PLoS ONE. 2008;3:e2573.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1, Shikata-cho, Okayama, 700-8558, Japan

    Bon Shoji, Fusao Ikeda, Haruhiko Kobashi, Tetsuya Yasunaka, Yasuhiro Miyake, Hidenori Shiraha, Akinobu Takaki, Kazuhiro Nouso, Yoshiaki Iwasaki & Kazuhide Yamamoto

  2. Department of Molecular Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

    Fusao Ikeda, Yasuhiro Miyake, Kazuhiro Nouso & Kazuhide Yamamoto

  3. Department of Internal Medicine, Okayama Saiseikai General Hospital, Okayama, Japan

    Shin-ichi Fujioka

Authors
  1. Bon Shoji
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fusao Ikeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shin-ichi Fujioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Haruhiko Kobashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tetsuya Yasunaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yasuhiro Miyake
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hidenori Shiraha
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Akinobu Takaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kazuhiro Nouso
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yoshiaki Iwasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Kazuhide Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fusao Ikeda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shoji, B., Ikeda, F., Fujioka, Si. et al. Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease. J Gastroenterol 45, 1172–1182 (2010). https://doi.org/10.1007/s00535-010-0266-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-010-0266-9

Keywords

Search

Navigation